| Schedule II - Valuation and Qualifying Accounts |
SCHEDULE II—Valuation and qualifying accounts March 31, 2024, 2023, and 2022 Dollars in thousands | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Additions | | | | | | Description | | Balance at Beginning of Period | | Charged to Costs and Expenses | | Charged to Other Accounts | Acquisition/Divestiture | | Deductions | | | Balance at End of Period | Year ended March 31, 2024: | | | | | | | | | | | | | | Deducted from asset accounts: | | | | | | | | | | | | | | Allowance for doubtful accounts | | $ | 3,620 | | | $ | 1,225 | | | $ | (3) | | $ | 64 | | | $ | 1,079 | | (1) | | $ | 3,827 | | | Deferred tax asset valuation allowance | | 15,978 | | | (805) | | | (17) | | — | | | — | | | | 15,156 | | | Total | | $ | 19,598 | | | $ | 420 | | | $ | (20) | | $ | 64 | | | $ | 1,079 | | | | $ | 18,983 | | | Reserves on balance sheet: | | | | | | | | | | | | | | Accrued general and product liability costs, net of insurance recoveries | | $ | 12,831 | | | $ | 2,226 | | | $ | — | | $ | — | | | $ | 2,706 | | (2) | | $ | 12,351 | | Year ended March 31, 2023: | | | | | | | | | | | | | | Deducted from asset accounts: | | | | | | | | | | | | | | Allowance for doubtful accounts | | $ | 5,717 | | | $ | 1,055 | | | $ | (96) | | $ | — | | | $ | 3,056 | | (1) | | $ | 3,620 | | | Deferred tax asset valuation allowance | | 16,147 | | | 77 | | | (246) | | — | | | — | | | | 15,978 | | | Total | | $ | 21,864 | | | $ | 1,132 | | | $ | (342) | | $ | — | | | $ | 3,056 | | | | $ | 19,598 | | | Reserves on balance sheet: | | | | | | | | | | | | | | Accrued general and product liability costs, net of insurance recoveries | | $ | 13,414 | | | $ | 3,025 | | | $ | — | | $ | — | | | $ | 3,608 | | (2) | | $ | 12,831 | | Year ended March 31, 2022: | | | | | | | | | | | | | | Deducted from asset accounts: | | | | | | | | | | | | | | Allowance for doubtful accounts | | $ | 5,686 | | | $ | 1,929 | | | $ | (170) | | $ | 227 | | | $ | 1,955 | | (1) | | $ | 5,717 | | | Deferred tax asset valuation allowance | | 15,103 | | | 242 | | | 255 | | 547 | | | — | | | | 16,147 | | | Total | | $ | 20,789 | | | $ | 2,171 | | | $ | 85 | | $ | 774 | | | $ | 1,955 | | | | $ | 21,864 | | | Reserves on balance sheet: | | | | | | | | | | | | | | Accrued general and product liability costs, net of insurance recoveries | | $ | 13,175 | | | $ | 6,648 | | | $ | — | | $ | — | | | $ | 6,409 | | (2) | | $ | 13,414 | |
_________________ (1)Uncollectible accounts written off, net of recoveries (2)Insurance claims and expenses paid
|